Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-78.35	48.41	223.56
Graham Fair Price	-10.42	75.57	84.36
PEG	142.36	-0.45	0.19
Price/Book	11.10	0.65	0.58
Price/Cash Flow	inf	0.00	-21.03
Prices/Earnings	21.86	6.52	5.35
Price/Sales	592.65	6.48	0.94
Price/FCF	inf	0.00	-21.03
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	482.21	0.34	0.06
ROA	-11.60	< 0.005	< 0.005
ROE	0.03	0.02	-8.83
ROIC	< 0.005	< 0.005	69.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	-0.52	1.30	-60.14
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.22	-0.06	-73.82
EPS QOQ	0.29	-0.14	-49.72
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	5.65	-0.84	-85.17
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	59.35	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.84	0.72	-14.49
Quick Ratio	0.31	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	107.78	101.12	-6.18
Cash	258.35	161.46	-37.51
Capex	-0.89	n.A.	n.A.
Free Cash Flow	-2.99	n.A.	n.A.
Revenue	67.10	10.10	-84.95
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	0.64	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	175.76	29.45	-83.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating